How Will the In-Vitro Transcription Templates Market Grow? Key Trends and Opportunities for 2025 and Beyond
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the in-vitro transcription templates market grown over the years?
In recent years, the market size of in-vitro transcription templates has witnessed a rapid expansion. It is projected to increase from $1.01 billion in 2024 to $1.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 23.7%. The notable growth during the historical period is a result of the upsurge in chronic disease incidences, amplified investments in research and development within the healthcare and pharmaceutical industries, enhancements in gene therapy technology, strategic collaborations, partnerships, and advancements in gene therapy.
What Is the forecasted market size and growth rate for the in-vitro transcription templates market?
The market size of in-vitro transcription templates is predicted to witness a surge in the upcoming years, possibly enlarging to a substantial $2.9 billion by 2029 with a CAGR of 23.4%. This projected expansion during the forecasted timeline can be ascribed to the continual progression in biotechnology, heightened focus on R&D initiatives, escalated utilization of in-vitro transcription templates, the requirement for early detection of diseases, and the climbing demand for mRNA-based vaccines. Significant trends predicted for the forecast period encompass evolution in RNA synthesis strategies, technological progress, enhancement in biotechnological methods, improvements in enzymatic synthesis procedures, and the amalgamation of automation with digitalization.
Get your in-vitro transcription templates market report here!
What are the major factors driving growth in the in-vitro transcription templates market?
The escalating emphasis on gene therapy is predicted to boost the in-vitro transcription templates market growth. Gene therapy, which amends genes within cells to treat or prevent diseases by rectifying flawed genes, has seen significant advances in its technologies like CRISPR. This technology, coupled with substantial investment and recent treatment successes, has broadened the focus on this method. In-vitro transcription templates aid gene therapy by supplying the RNA molecules needed for mRNA-based therapies, siRNA-based therapies, and gene editing technologies. They enable the treatment of genetic disorders and diseases. For example, the US-based federal agency, the Food and Drug Administration (FDA) of the Department of Health and Human Services, reported in March 2024 that they approved 36 gene therapies. They revealed that there are 500 additional therapies in the pipeline and anticipate approval for 10-20 annually by 2025. Consequently, this surge in emphasis on gene therapy is propelling the in-vitro transcription templates market growth.
What key areas define the segmentation of the global in-vitro transcription templates Market?
The in-vitro transcription templates market covered in this report is segmented –
1) By Treatment: Vaccine, Therapeutic
2) By Research Stage: Exploratory, Clinical
3) By Disease: Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users
Subsegments:
1) By Vaccine: MRNA Vaccines, DNA Vaccines
2) By Therapeutic: Gene Therapy, RNA-Based Therapeutics
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15838&type=smp
What are the top market players propelling the growth of the in-vitro transcription templates industry?
Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia
What key trends are currently impacting the in-vitro transcription templates market’s development?
Key players within the in-vitro transcription templates industry are focusing on the development of self-amplifying RNA synthesis services as a way to upgrade the efficiency, effectiveness, and affordability of RNA-based treatments, as well as to refine patient outcomes across a diverse range of therapeutic applications. This technology facilitates the replication of RNA within host cells, dilating protein expression from a minimal RNA input and thus improving the overall performance of RNA-related treatments. For example, GenScript Biotech Corporation, a United States biotechnology firm, introduced its self-amplifying RNA (saRNA) synthesis service in May 2024, thereby broadening the scope of its in vitro transcription RNA synthesis offerings. This service amplifies the power and efficacy of vaccines, immunotherapies, and gene therapies by ensuring robust protein production from a minimal RNA sample. Advantages of the saRNA platform include dosage reduction, lowered manufacturing costs and enhanced patient outcomes. Backed by thorough research and development efforts, GenScript’s saRNA is characterized by its high purity and superior protein production capabilities, ensuring dependable performance.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15838
What regions are dominating the in-vitro transcription templates market growth?
North America was the largest region in the in-vitro transcription templates market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024
Enzymes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report
Healthcare Specialty Enzymes Global Market Opportunities And Strategies To 2031
https://www.thebusinessresearchcompany.com/report/healthcare-specialty-enzymes-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
